During the past decade, GBG Forschungs GmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GBG Forschungs GmbH" #1 collaborator was "German Adjuvant Breast Cancer Group" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Goethe University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "GBG Forschungs GmbH" are "Breast Cancer" (3 trials), "Metastatic Breast Cancer" (2 trials) and "Primary Breast Cancer" (1 trials). Many other conditions were trialed in "GBG Forschungs GmbH" in a lesser frequency.

Most popular intervention types in "GBG Forschungs GmbH" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil, Epirubicin, Cyclophosphamide, Docetaxel" (1 trials), "Adriamycin (Doxorubicin), Docetaxel, Tamoxifen" (1 trials), "Adriamycin (Doxorubicin), Docetaxel, Tamoxifen, Cyclophosphamid" (1 trials), "Nab-Paclitaxel" (1 trials) and "Pazopanib plus capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "GBG Forschungs GmbH" are 5 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "GBG Forschungs GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in GBG Forschungs GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in GBG Forschungs GmbH, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".